Thompson C S G, Asimakopoulos P, Evans A, Vernham G, Hay A J, Nixon I J
Department of Otolaryngology, Head and Neck Surgery, Edinburgh Cancer Centre, Western General Hospital, Scotland, UK.
J Laryngol Otol. 2020 Mar;134(3):256-262. doi: 10.1017/S0022215120000341. Epub 2020 Feb 21.
Total laryngectomy is often utilised to manage squamous cell carcinoma of the larynx or hypopharynx. This study reports on surgical trends and outcomes over a 10-year period.
A retrospective review of patients undergoing total laryngectomy for squamous cell carcinoma was performed (n = 173), dividing patients into primary and salvage total laryngectomy cohorts.
A shift towards organ-sparing management was observed. Primary total laryngectomy was performed for locoregionally advanced disease and utilised reconstruction less than salvage total laryngectomy. Overall, 11 per cent of patients developed pharyngocutaneous fistulae (primary: 6 per cent; salvage: 20 per cent) and 11 per cent neopharyngeal stenosis (primary: 9 per cent; salvage: 15 per cent). Pharyngocutaneous fistulae rates were higher in the reconstructed primary total laryngectomy group (24 per cent; 4 of 17), compared with primary closure (3 per cent; 3 of 90) (p = 0.02). Patients were significantly more likely to develop neopharyngeal stenosis following pharyngocutaneous fistulae in salvage total laryngectomy (p = 0.01) and reconstruction in primary total laryngectomy (p = 0.02). Pre-operative haemoglobin level and adjuvant treatment failed to predict pharyngocutaneous fistulae development.
Complications remain hard to predict and there are continuing causes of morbidity. Additionally, prior treatment continues to affect surgical outcomes.
全喉切除术常用于治疗喉或下咽鳞状细胞癌。本研究报告了10年间的手术趋势和结果。
对接受全喉切除术治疗鳞状细胞癌的患者进行回顾性分析(n = 173),将患者分为初次全喉切除术组和挽救性全喉切除术组。
观察到向器官保留治疗的转变。初次全喉切除术用于局部晚期疾病,与挽救性全喉切除术相比,较少使用重建术。总体而言,11%的患者发生咽皮肤瘘(初次手术:6%;挽救性手术:20%),11%的患者发生新咽狭窄(初次手术:9%;挽救性手术:15%)。重建的初次全喉切除术组的咽皮肤瘘发生率较高(24%;17例中的4例),而一期缝合组较低(3%;90例中的3例)(p = 0.02)。在挽救性全喉切除术中,患者在发生咽皮肤瘘后发生新咽狭窄的可能性显著增加(p = 0.01),在初次全喉切除术中,重建后发生新咽狭窄的可能性显著增加(p = 0.02)。术前血红蛋白水平和辅助治疗未能预测咽皮肤瘘的发生。
并发症仍然难以预测,且存在持续的发病原因。此外,先前的治疗继续影响手术结果。